279 related articles for article (PubMed ID: 30306221)
1. Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
Torres L; Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
Osteoporos Int; 2019 Feb; 30(2):441-449. PubMed ID: 30306221
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
3. Low bone mineral density of vertebral lateral projections can predict spinal radiographic damage in patients with ankylosing spondylitis.
Kim JW; Chung MK; Lee J; Kwok SK; Kim WU; Park SH; Ju JH
Clin Rheumatol; 2019 Dec; 38(12):3567-3574. PubMed ID: 31402392
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
5. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
Grazio S; Kusić Z; Cvijetić S; Grubišić F; Balenović A; Nemčić T; Matijević-Mikelić V; Punda M; Sieper J
Rheumatol Int; 2012 Sep; 32(9):2801-8. PubMed ID: 21858541
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
[TBL] [Abstract][Full Text] [Related]
7. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
[TBL] [Abstract][Full Text] [Related]
8. The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study.
Klingberg E; Oleröd G; Hammarsten O; Forsblad-d'Elia H
Osteoporos Int; 2016 Jun; 27(6):2027-33. PubMed ID: 26809190
[TBL] [Abstract][Full Text] [Related]
9. Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis.
Gamez-Nava JI; de la Cerda-Trujillo LF; Vazquez-Villegas ML; Cons-Molina F; Alcaraz-Lopez MF; Zavaleta-Muñiz SA; Rocha-Muñoz AD; Martinez-Garcia EA; Corona-Sanchez EG; Salazar-Paramo M; Fajardo-Robledo NS; Olivas-Flores EM; Cardona-Muñoz EG; Gonzalez-Lopez L
Scand J Rheumatol; 2016 Nov; 45(6):480-490. PubMed ID: 27218482
[TBL] [Abstract][Full Text] [Related]
10. Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.
Deminger A; Klingberg E; Lorentzon M; Geijer M; Göthlin J; Hedberg M; Rehnberg E; Carlsten H; Jacobsson LT; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Dec; 19(1):273. PubMed ID: 29216909
[TBL] [Abstract][Full Text] [Related]
11. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment.
Klingberg E; Lorentzon M; Mellström D; Geijer M; Göthlin J; Hilme E; Hedberg M; Carlsten H; Forsblad-d'Elia H
Arthritis Res Ther; 2012 May; 14(3):R108. PubMed ID: 22569245
[TBL] [Abstract][Full Text] [Related]
13. Hypovitaminosis D in Patients with Ankylosing Spondylitis: Frequency and Consequences.
Elolemy G; Hassan W; Nasr M; Baraka E
Curr Rheumatol Rev; 2021; 17(4):365-372. PubMed ID: 33687883
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density, bone metabolism-related factors, and microRNA-218 are correlated with disease activities in Chinese ankylosing spondylitis patients.
Liu J; Zhao L; Yang X; Liu C; Kong N; Yu Y; Xuan D; Wan W; Xue Y
J Clin Lab Anal; 2022 Feb; 36(2):e24223. PubMed ID: 34984723
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis.
Speden DJ; Calin AI; Ring FJ; Bhalla AK
J Rheumatol; 2002 Mar; 29(3):516-21. PubMed ID: 11908565
[TBL] [Abstract][Full Text] [Related]
16. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
Maksymowych WP; Landewé R; Conner-Spady B; Dougados M; Mielants H; van der Tempel H; Poole AR; Wang N; van der Heijde D
Arthritis Rheum; 2007 Jun; 56(6):1846-53. PubMed ID: 17530713
[TBL] [Abstract][Full Text] [Related]
17. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters.
Sakellariou GT; Iliopoulos A; Konsta M; Kenanidis E; Potoupnis M; Tsiridis E; Gavana E; Sayegh FE
Joint Bone Spine; 2017 May; 84(3):309-315. PubMed ID: 27369645
[TBL] [Abstract][Full Text] [Related]
19. Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.
Braun J; Buehring B; Baraliakos X; Gensler LS; Porter B; Quebe-Fehling E; Haemmerle S
BMC Musculoskelet Disord; 2021 Dec; 22(1):1037. PubMed ID: 34903218
[TBL] [Abstract][Full Text] [Related]
20. Low levels of serum uric Acid increase the risk of low bone mineral density in young male patients with ankylosing spondylitis.
Kang KY; Hong YS; Park SH; Ju JH
J Rheumatol; 2015 Jun; 42(6):968-74. PubMed ID: 25834199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
